Digipath
CHM Cannabis
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

This changeover in the movie industry could be

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
wimuskyfisherman Member Profile
 
Followed By 6
Posts 2,081
Boards Moderated 0
Alias Born 11/26/14
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/6/2018 11:18:22 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 12/6/2018 11:14:13 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/6/2018 6:11:40 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 11/30/2018 5:53:34 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/28/2018 2:44:21 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/28/2018 2:41:17 PM
GD Entertainment and Technology (GDET) Benefit from the transactional side of Bitcoin InvestorsHub NewsWire - 11/28/2018 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2018 5:37:11 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:38:31 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:24:23 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:20:56 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/27/2018 3:17:34 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2018 8:12:16 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/27/2018 6:10:06 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 5:25:52 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 5:23:41 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/21/2018 4:42:54 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 12:05:37 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/21/2018 12:01:51 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/21/2018 6:06:39 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/6/2018 6:10:46 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/6/2018 6:10:14 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 11/6/2018 6:10:14 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/26/2018 4:30:50 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 10/26/2018 4:20:44 PM
wimuskyfisherman   Thursday, 11/09/17 03:34:36 PM
Re: tilator post# 31181
Post # of 38229 
This changeover in the movie industry could be very disruptive. What I see is someone creating a business that will lower the cut for the theatre owners and people making the films. I don't see how they will get away with "eating someone else's lunch" while those people passively sit back and watch. Should be interesting.

A big problem I see is at times when they can fill the theatres easily at full price- premiers, weekends, holidays, etc. They are not going to like giving half the seats away at lower prices.

The reason I have not signed up for this service is I was able to get a Marcus Rewards card for free. On Tuesday nights all movies are $5 plus with the rewards program I get free popcorn as well. So I might go 1-2 times per month. Never more than 2... And I will get free popcorn too! And if I don't go at all, I pay nothing!


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist